OrbiMed Advisors LLC

SEC CIK: 0001055951
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NKTR holding history

Nektar Therapeutics in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overview All 13F holders of NKTR Full Q2 2026 holdings

Shares (Q2 2026): 465,346
Value: $32.5M
% of portfolio: 0.6%
Quarters held: 3; Since Q1 2023

Holdings of NKTR by OrbiMed Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	465,346	$32.5M	0.6%	+190,346+69.2%	Added	Holders
Q1 2026	275,000	$19.8M	0.4%	+275,000	New	Holders
Q2 2023	0	$0	0.0%	−1,034,059−100.0%	Sold out	Holders
Q1 2023	1,034,059	$726.8K	<0.1%	+1,034,059	New	Holders